Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P31270 (
RSAT
)
31
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several long non-coding RNAs (lncRNAs) play important roles in the regulation of liver metastasis in
colorectal cancer
(
CRC
) patients. We previously described the potential involvement of
HOMEOBOX A11
(
HOXA11
) antisense RNA (
HOXA11
-AS), miR-125a-5p, and peptidyl arginine deiminase 2 (PADI2) in promoting liver metastasis in
CRC
patients. In the present study, we verified the significant upregulation of
HOXA11
-AS and PADI2, as well as the downregulation of miR-125a-5p, in
CRC
patients with liver metastasis. Overexpression and knockdown studies of
HOXA11
-AS or PADI2, as well as gain-/loss-of-function studies of miR-125a-5p, revealed a positive correlation between
HOXA11
-AS and PADI2 and a negative correlation with miR-125a-5p in the regulation of liver metastasis in
CRC
cell lines. Overall, we conclude that
HOXA11
-AS promotes liver metastasis in
CRC
by functioning as a miR-125a-5p sponge and describe a novel
HOXA11
-AS-miR-125a-5p-PADI2 regulatory network involved in
CRC
liver metastasis.
...
PMID:The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer. 2905 Mar 8